Financials
- Market Capitalization 3.7 B
- Employee 1 184
- Founded 2015
- CEO Christian Behrenbruch
- Website www.telixpharma.com
- Headquarter Australia
- FIGI BBG01N69K900
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 1500 | RLAY Relay Therapeutics, Inc. - Common Stock | 17.36 USD | -3.45% | -5.65% | -8.39% | +183.66% | 3.80 B USD | ||
| 1511 | TNGX Tango Therapeutics, Inc. - Common Stock | 22.22 USD | -8.07% | +2.68% | -7.34% | +165.47% | 3.75 B USD | ||
| 1559 | VCYT Veracyte, Inc. - Common Stock | 43.11 USD | -2.07% | -2.11% | +4.94% | +16.83% | 3.47 B USD | ||
| 1581 | XENE Xenon Pharmaceuticals Inc. - Common Shares | 34.42 USD | -3.88% | -4.89% | -42.01% | -15.62% | 3.33 B USD |